Taiwan FDA registration efb2a580b5aea4dbfeff4da8b0b571d7
Silvi intraarticular injection
TW: 希樂維關節腔注射液
Taiwan·Risk Class 3·VSY Biotechnology; APTISSEN SA·Registered Jul 07, 2023 – Jul 07, 2028ActiveRegistration details
- Analysis ID
- efb2a580b5aea4dbfeff4da8b0b571d7
- Customs Code
- DHA05603666909
Company information
- Manufacturer
- VSY Biotechnology; APTISSEN SA
- Manufacturer Country
- Türkiye;;Switzerland
- Authorized Representative
- Best Pharma Co., Ltd.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- N Orthopedics
- Product Type (Level 2)
- N.0003 關節腔玻尿酸植入物
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Jul 07, 2023
- Expiry Date
- Jul 07, 2028
About this record
Access comprehensive regulatory information for Silvi intraarticular injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number efb2a580b5aea4dbfeff4da8b0b571d7 and manufactured by VSY Biotechnology; APTISSEN SA. The authorized representative in Taiwan is Best Pharma Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices